HomeCompareMRDH vs MRK

MRDH vs MRK: Dividend Comparison 2026

MRDH yields 18181.82% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRDH wins by $20382968138483965952.00M in total portfolio value
10 years
MRDH
MRDH
● Live price
18181.82%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20382968138483965952.00M
Annual income
$20,164,798,479,641,134,000,000,000.00
Full MRDH calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — MRDH vs MRK

📍 MRDH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodMRDHMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, MRDH + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
MRDH pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MRDH
Annual income on $10K today (after 15% tax)
$1,545,454.55/yr
After 10yr DRIP, annual income (after tax)
$17,140,078,707,694,964,000,000,000.00/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRDH beats the other by $17,140,078,707,694,964,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MRDH + MRK for your $10,000?

MRDH: 50%MRK: 50%
100% MRK50/50100% MRDH
Portfolio after 10yr
$10191484069241982976.00M
Annual income
$10,082,399,239,820,567,000,000,000.00/yr
Blended yield
98.93%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MRDH
No analyst data
Altman Z
-14.7
Piotroski
4/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MRDH buys
0
MRK buys
0
No recent congressional trades found for MRDH or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricMRDHMRK
Forward yield18181.82%2.76%
Annual dividend / share$2.00$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%32.7%
Portfolio after 10y$20382968138483965952.00M$56.8K
Annual income after 10y$20,164,798,479,641,134,000,000,000.00$9,798.13
Total dividends collected$20368560651224936448.00M$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: MRDH vs MRK ($10,000, DRIP)

YearMRDH PortfolioMRDH Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$1,828,882$1,818,181.82$11,206$366.19+$1.82MMRDH
2$312,726,966$310,770,062.56$12,650$502.35+$312.71MMRDH
3$49,997,862,140$49,663,244,286.24$14,407$694.19+$49997.85MMRDH
4$7,474,070,205,933$7,420,572,493,443.65$16,585$967.82+$7474070.19MMRDH
5$1,044,712,232,322,833$1,036,714,977,202,484.10$19,342$1,363.89+$1044712232.30MMRDH
6$136,547,911,758,351,100$135,430,069,669,765,680.00$22,913$1,947.19+$136547911758.33MMRDH
7$16,689,313,388,956,088,000$16,543,207,123,374,653,000.00$27,662$2,823.89+$16689313388956.06MMRDH
8$1,907,542,220,817,720,100,000$1,889,684,655,491,537,200,000.00$34,159$4,173.35+$1907542220817720.25MMRDH
9$203,896,877,423,206,970,000,000$201,855,807,246,932,000,000,000.00$43,337$6,308.80+$203896877423206976.00MMRDH
10$20,382,968,138,483,967,000,000,000$20,164,798,479,641,134,000,000,000.00$56,776$9,798.13+$20382968138483965952.00MMRDH

MRDH vs MRK: Complete Analysis 2026

MRDHStock

Meridian Holdings, Inc., through its subsidiaries, provides healthcare management and information system solutions in the United States. The company offers guaranteed insured healthcare savings account program plan for individuals; and healthcare services through integrated network of independent medical practices, as well as operates as an accountable care organization with approximately 600 contracted ACO participants, providers, and suppliers. It also provides turnkey support services for implementation and operation of telemedicine, telehealth, and other information technology services in health care and associated environments; and administers a range of medical and health related services through a network of healthcare providers, as well as operates as an energy and natural resource management company. The company was incorporated in 1998 and is based in Hawthorne, California.

Full MRDH Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this MRDH vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MRDH vs SCHDMRDH vs JEPIMRDH vs OMRDH vs KOMRDH vs MAINMRDH vs JNJMRDH vs ABBVMRDH vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.